Early detection of systemic infections

[11] Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (06) : 471 - 473

[12] Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) : 2229 - 2235

[13] Effects of nosocomial candidemia on outcomes of critically ill patients [J]. AMERICAN JOURNAL OF MEDICINE, 2002, 113 (06) : 480 - 485

[14] Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) : 60 - 66

[15] Byl B, 1998, ACTA CLIN BELG, V53, P355

[16] CLINICAL ISSUES OF BLOOD CULTURES [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (08) : 841 - 849

[17] The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia [J]. JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (12) : 1010 - 1012

[18] Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) : 208 - 213

[19] Epidemiology and outcome of nosocomial and community-onset bloodstream infection [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) : 3655 - 3660

[20] The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive cave unit [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) : 976 - 981

[11] Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (06) : 471 - 473

[12] Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) : 2229 - 2235

[13] Effects of nosocomial candidemia on outcomes of critically ill patients [J]. AMERICAN JOURNAL OF MEDICINE, 2002, 113 (06) : 480 - 485

[14] Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) : 60 - 66

[15] Byl B, 1998, ACTA CLIN BELG, V53, P355

[16] CLINICAL ISSUES OF BLOOD CULTURES [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (08) : 841 - 849

[17] The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia [J]. JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (12) : 1010 - 1012

[18] Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) : 208 - 213

[19] Epidemiology and outcome of nosocomial and community-onset bloodstream infection [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) : 3655 - 3660

[20] The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive cave unit [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) : 976 - 981